Pages that link to "Q33735287"
Jump to navigation
Jump to search
The following pages link to Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria (Q33735287):
Displaying 36 items.
- Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease (Q26747131) (← links)
- Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles (Q28484239) (← links)
- CE-MS for the analysis of intact proteins 2010-2012. (Q34480662) (← links)
- Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress. (Q35762675) (← links)
- Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells (Q35956447) (← links)
- Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification (Q36321624) (← links)
- Urinary proteomics for early diagnosis in diabetic nephropathy (Q36410737) (← links)
- Identification of urinary proteins potentially associated with diabetic kidney disease. (Q37460323) (← links)
- Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development (Q37714579) (← links)
- Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. (Q37871572) (← links)
- Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications (Q37876853) (← links)
- Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications (Q38091336) (← links)
- Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer (Q38130892) (← links)
- Proteomic urinary biomarker approach in renal disease: from discovery to implementation (Q38196316) (← links)
- Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics (Q38340351) (← links)
- Proteomic biomarkers in kidney disease: issues in development and implementation (Q38341211) (← links)
- Body fluid peptide and protein signatures in diabetic kidney diseases (Q38553924) (← links)
- Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes (Q38553932) (← links)
- Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management (Q38906256) (← links)
- Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases. (Q38943789) (← links)
- Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy (Q38961899) (← links)
- The long path towards implementation of clinical proteomics: Exemplified based on CKD273. (Q39055330) (← links)
- Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis (Q39094572) (← links)
- Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease (Q39427234) (← links)
- Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures! (Q41173762) (← links)
- A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. (Q44319128) (← links)
- The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome (Q47587893) (← links)
- Urinary peptidomics in kidney disease and drug research (Q47781932) (← links)
- Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension. (Q53536253) (← links)
- Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria. (Q55112495) (← links)
- Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease (Q58107393) (← links)
- Sample stacking by field-amplified sample injection and sweeping for simultaneous analysis of acidic and basic components in clinic application (Q84465829) (← links)
- Targeting the progression of chronic kidney disease (Q89723568) (← links)
- Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future (Q91755162) (← links)
- Urinary Peptidomic Biomarkers in Kidney Diseases (Q92255911) (← links)
- Urinary peptidomics and bioinformatics for the detection of diabetic kidney disease (Q92978454) (← links)